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Abstract
Thoracic aortic aneurysm after heart transplantation is a rare but serious complication. The authors describe 3 cases (0.6%) 
of thoracic aortic aneurysm during 20 years of follow-up on 485 heart transplant patients at their institution. Dissected and 
non-dissected thoracic aortic aneurysms, diagnosed 23 to 38 months post transplantation, were treated with surgical repair 
or repeat transplantation. Two patients died postoperatively of multiorgan failure, including one with septic shock. One patient
was discharged in good health. Surgical repair of aortic lesions in cardiac allograft patients, including repeat transplantation 
in cases of allograft vasculopathy, continue to carry substantial risk to the patient.
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Introduction
Diseases of donor and recipient aortas are rare but
dangerous complications after heart transplantation [1]. In
our department, 485 heart transplantation procedures
including 2 repeat transplantations were performed between
1988 and 2007. This paper describes 3 cases (0.6%) of
thoracic aortic aneurysm occurring during this 19-year
follow-up period.
Patients
All patients provided verbal informed consent for
inclusion of their cases in this publication. Approval was
obtained from the appropriate ethics board and institutional
review board for this research.
Patient 1
This 48-year-old man received a control coronary angio-
graphy because of transplant vasculopathy 38 months post
heart transplantation. The angiographic examination re-
vealed a chronic aortic aneurysm with dissection type II De
Bakey. A 10-cm dissection that terminated in the aortic suture
line was confirmed by computed tomography (CT) scan. Due
to vasculopathy with left ventricular ejection fraction 20%,
retransplantation was performed. The donor aorta was
successfully anastomosed with no resulting changes to the
recipient aorta. After surgery, high doses of inotropic agents,
mechanical ventilation, and broad-spectrum antibiotics were
required. Due to anuria through the second postoperative
day, the patient required haemodialysis. Despite intensive
treatment, the patient’s overall medical condition remained
severe and multiorgan dysfunction ensued. The patient died
10 days after the repeat transplantation procedure.
Patient 2
A 53-year-old man was admitted 36 months post heart
transplantation for recurrent severe pain between the
shoulder blades, severe dyspnoea at rest, and syncope. The
chest X-ray, echocardiography, and angio-CT scan of the
thoracic aorta revealed a huge non-dissected aneurysm of
the ascending aorta and aortic arch with maximum
diameter 14.5 cm (Fig. 1). The aneurysm extended up to the
origin of the left subclavian artery and caused constriction
of the trachea. Emergency aneurysmectomy was pursued
based on first symptoms of recurrent laryngeal nerve
compression (cough) and severe dyspnoea at rest. During
the operation, a pseudoaneurysm (maximum dimension 
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12 cm) originating in the suture line was observed. The
aneurysmectomy was performed using extracorporeal
circulation (arterial cannulation through the femoral artery)
in deep hypothermia with temporal cardiac arrest.
Alloplasty of the aorta was performed using a 28-mm
straight prosthesis (Sulzer Vascutek, Renfrewshire, UK)
with hone-shaped anastomosis of extracranial arteries into
the prosthesis. In the postoperative period, multiorgan
dysfunction and septic shock (Pseudomonas aeruginosa)
occurred. The patient died on the 20th day post surgery.
Patient 3
A 53-year-old man was admitted to the hospital with
severe right ventricular failure 23 months post heart trans-
plantation. Based on echocardiography and aortography, an
aneurysm of the Valsalva sinus was diagnosed. Due to
difficulty interpreting these imaging tests, magnetic re-
sonance imaging (MRI) and CT scan were performed, which
identified a pseudoaneurysm originating in the ascending
aorta suture line causing compression of the pulmonary
artery and right ventricle (Fig. 2). The aneurysmectomy was
done by use of extracorporeal circulation (femoral artery
cannulation) in deep hypothermia with temporal cardiac
arrest. After removal of the pseudoaneurysm, lateral plasty of
the ascending aorta was performed using a Hemashield Gold
patch (Boston Scientific Corporation, Natick, Massachusetts).
Intraoperatively, Pseudomonas-like signs of infection were
present (Pseudomonas aeruginosa) and antibiotics (imi-
penem-cilastatin, amoxicillin clavulanate, and metronidazole)
were administered. The patient was discharged in good
condition after 50 days of hospitalization.
Comment
Heart transplantation remains the most effective
treatment for end-stage heart failure. The introduction of
new, individually adapted immunosuppressive therapy
models, as well as improvements in postoperative care,
have improved the life expectancy and quality of life after
heart transplantation [2]. The most frequent factors limiting
life expectancy in the first year after heart transplantation
are allograft failure, non-cytomegalovirus infection, multi-
organ failure, and acute rejection [3]. In the long term (i.e. 
> 5 years), the most important contributors to mortality are
allograft vasculopathy, late graft failure, malignant tumours,
and non-cytomegalovirus infection [3].
Although relatively rare, aortic lesions post heart trans-
plantation are considered to be an adverse consequence of
the transplantation itself and the required immunosup-
pressive therapy [5]. Denervation of the transplanted heart
and the absence of early chest pain make timely diagnosis
particularly challenging [4]. Aortic lesions tend to progress
such that surgical repair or repeat transplantation is
necessary [5].
Reports of aortic aneurysm in cardiac allograft patients
in the literature are sparse. Vigano reported on a series of 
9 cardiac allograft patients with aortic complications, inclu-
ding dissected aneurysm, pseudoaneurysm, and aortic
rupture [5]. It was noted that the most frequent risk factors
for aortic aneurysm were infections, hypertension after heart
transplantation, and compliance mismatch between the
donor and recipient aorta. Hypertension (patients 1 and 2)
and infection (patient 3) were present in our cases as well. 
After heart transplantation, patients are at increased
risk for serious infections as a result of the need for
Fig. 1. Giant aneurysm of the ascending aorta and aortic arch (CT
reconstruction) in patient 2
Fig. 2. Pseudoaneurysm originating in ascending aorta (suture line)
with compression of pulmonary artery and right ventricle in patient 3
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permanent immunosuppressive treatment to prevent graft
rejection. The aggressive immunosuppression employed
after repeat transplantation generates an additional risk of
multiorgan dysfunction or general infection. Such compli-
cations appear to be major factors in determining post-
operative results. Surgical repair of aortic lesions in cardiac
allograft patients are often necessary, with repeat trans-
plantation being the “procedure of choice” in cases of graft
vasculopathy, though such surgeries continue to carry
substantial risk to the patient.
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